多发性硬化是否影响全髋关节置换术后的住院围手术期结局
基于美国全国住院患者样本2002至2013年数据,比较5899例多发性硬化(MS)与2,723,652例非MS全髋关节置换术(THA)患者,并按年龄、性别、种族、合并症评分和手术年份3:1匹配后分析。MS患者THA年患病率从2002年每1000例THA中1.36例升至2013年2.54例(P=0.004)。匹配队列中MS患者任何手术并发症(OR=1.18;95%CI 1.02-1.37)、任何内科并发症(OR=1.55;95%CI 1.34-1.81)风险更高,平均住院时间延长8.24%(95%CI 5.61-10.94;P<0.0001),出院转至护理机构的可能性更高(OR=2.09;95%CI 1.82-2.40)。
要点
- MS患者THA年患病率从2002年1.36/1000例THA升至2013年2.54/1000例THA(P=0.004)。
- 匹配后MS患者任何手术并发症OR=1.18(95%CI 1.02-1.37),任何内科并发症OR=1.55(95%CI 1.34-1.81)。
- 匹配后MS患者平均住院时间延长8.24%(95%CI 5.61-10.94;P<0.0001),转护理机构OR=2.09(95%CI 1.82-2.40)。
核心结论
- 骨科医生应认识到MS患者THA术后可能存在更高的风险。
- 神经科医生和其他执业者可能有助于优化和加强潜在THA候选者的术前护理,并就MS患者髋部问题的适当干预时机提供指导。
研究设计与样本
- 使用2002至2013年全国住院患者样本,识别5899例MS和2,723,652例非MS THA患者。
- 比较年度趋势、人口学和合并症后,按年龄、性别、种族、合并症评分和手术年份以3:1将非MS THA患者与MS THA患者匹配。
- 采用回归分析比较围手术期并发症(任何、手术、内科)、住院时间(LOS)和出院去向。
主要发现
- THA患者中MS年患病率从2002年每1000例THA中1.36例增至2013年2.54例(P=0.004)。
- MS患者更年轻、更可能为女性、使用皮质激素、患有髋部骨坏死并存在步态异常。
- 与匹配队列相比,MS患者任何手术并发症风险更高(OR=1.18;95%CI 1.02-1.37)。
- 与匹配队列相比,MS患者任何内科并发症风险更高(OR=1.55;95%CI 1.34-1.81)。
- 与匹配队列相比,MS患者平均LOS延长8.24%(95%CI 5.61-10.94;P<0.0001),出院转至护理机构的可能性更高(OR=2.09;95%CI 1.82-2.40)。
关键数值与推荐
- MS患者任何手术并发症OR=1.18(95%CI 1.02-1.37)。
- MS患者任何内科并发症OR=1.55(95%CI 1.34-1.81)。
- MS患者平均LOS延长8.24%(95%CI 5.61-10.94;P<0.0001)。
- MS患者出院转至护理机构OR=2.09(95%CI 1.82-2.40)。
临床怎么用
- 骨科医生应认识到MS患者THA术后可能存在更高的风险。
- 神经科医生和其他执业者可能有助于优化和加强潜在THA候选者的术前护理,并就MS患者髋部问题的适当干预时机提供指导。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is a paucity of studies evaluating the short-term perioperative outcomes of total hip arthroplasty (THA) in multiple sclerosis (MS) patients. Therefore, this study evaluated (1) patient factors; and (2) patient outcomes in MS THA patients compared to non-MS THA patients. METHODS: The Nationwide Inpatient Sample from 2002 to 2013 identified 5899 MS and 2,723,652 non-MS THA patients. Yearly trends, demographics, and comorbidities were compared, and then non-MS THA patients were matched (3:1) to MS THA patients by age, gender, race, comorbidity score, and surgery year. Regression analyses compared perioperative complications (any, surgical, medical), length of stay (LOS), and discharge dispositions. RESULTS: The annual prevalence of MS in THA patients increased from 1.36 per 1000 THAs in 2002 to 2.54 per 1000 THAs in 2013 (P = .004). MS patients were younger, more likely female, take corticosteroids, have hip osteonecrosis, and have gait abnormalities. Compared to matched cohort, MS patients had a higher risk of any surgical (odds ratio [OR] = 1.18; 95% confidence interval [95% CI], 1.02-1.37) and any medical (OR = 1.55; 95% CI, 1.34-1.81) complications, an 8.24% longer mean LOS (95% CI, 5.61-10.94; <0.0001) and were more likely to be discharged to a care facility (OR = 2.09; 95% CI, 1.82-2.40). CONCLUSION: Orthopedic surgeons should be cognizant of the potential increased risks after THA in MS patients. Neurologists and other practitioners may help optimize and enhance the preoperative care of potential THA candidates, and provide guidance as to the appropriate timing of intervention for hip issues in MS patients.
引用
- Newman JM, Naziri Q, Chughtai M, et al. Does Multiple Sclerosis Affect the Inpatient Perioperative Outcomes After Total Hip Arthroplasty? J Arthroplasty. 2017. PMID: 28780224. doi:10.1016/j.arth.2017.07.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。